Can a tiny spacer restore shoulder function in massive tears?

NCT ID NCT07745647

Not yet recruiting Disease control Sponsor: Voll Medical Technologies Ltd. Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This early-stage trial is testing a new non-degradable shoulder spacer in people over 50 with massive rotator cuff tears. The spacer is designed to be placed in the shoulder to help improve pain and function. The study will look at how safe the device is and whether it helps with symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Voll Non-Degradable Shoulder Spacer
What this could lead to: If successful, this spacer could offer a new treatment option for massive rotator cuff tears, potentially reducing pain and improving shoulder function without the need for more invasive surgery.
What could go wrong: This is a very early, first-in-human study with only 10 participants, so safety and effectiveness are not yet established. The device may not provide the expected benefits or could cause complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASSIVE ROTATOR CUFF TEAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MASSIVE ROTATOR CUFF TEAR MASSIVE ROTATOR CUFF TEARS

Contacts and locations

Locations

Assuta Ashdod Hospital

Ashdod, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.